Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

The Oxford Science Park sponsors the OXBA Innovation Award for the fifth year 

The Oxford Science Park sponsors the OXBA Innovation Award for the fifth year . Apply now to join previous winners such as 2019’s Oxford Biomedica  

Read the rest of entry »

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)

Read the rest of entry »

VivoPlex expands to Oxford medtech & digital health cluster

VivoPlex Group Ltd, which is transforming fertility treatment with precision medicine, has expanded to take on laboratory and office premises on Milton Park, Oxford.

Read the rest of entry »

Grey Wolf completes £2.5 million Series A2 financing for development of therapies targeting ERAP2

Oxford, UK – 9th January 2020 – Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for immuno-oncology (IO), today announces it has completed a £2.5 million ($3.3 million) Series A2 financing round with existing leading international healthcare investors Andera Partners and Canaan.

Read the rest of entry »

Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology

Hikma Pharmaceuticals PLC (Hikma, Group / LSE: HIK / NASDAQ Dubai: HIK / OTC: HKMPY) (rated Ba1/stable Moody’s and BB+/positive S&P), the multinational generic pharmaceutical company, and Arecor Ltd, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announce they have entered into an exclusive agreement to co-develop a new, ready-to-use injectable medicine in the US through Hikma’s affiliate, Hikma Pharmaceuticals USA Inc.

Read the rest of entry »

Absolute Antibody Launches VivopureX™ Recombinant Antibodies for In Vivo Research

Redcar, UK, January 7, 2020. Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the launch of its VivopureX™ recombinant mouse antibodies for in vivo research in mouse models.

Read the rest of entry »

Efficient Isolation of Circulating Cell Free DNA

AMSBIO has expanded its range of cfPure™ Cell Free DNA Purification Kits for rapid and efficient isolation of circulating cell free DNA (cfDNA).  A new cfPure™Max kit is now available for use on samples of 5mLs volume or greater.

Read the rest of entry »

RSSL's First QP Connect Symposium

RSSL is proud to announce that its first QP Connect Symposium, held in conjunction with the PHSS, is to be held 12th May 2020.

Read the rest of entry »

Understanding the 3D shape of Oligodendrocytes

AMSBIO reports on the pioneering research published** by scientists at Stanford University Medical School that has cited Mimetix® aligned 3D cell culture scaffold supplied by the company to understand the architecture of the myelin sheaths which insulate neuronal axons, so they can transmit electrical impulses quickly and efficiently.

Read the rest of entry »

Pathios Therapeutics closes US$8.8M Series A and appoints Stuart Hughes as CEO

OXFORD, UK 18th DECEMBER 2019: Pathios Therapeutics Limited (“Pathios”), an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, today announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia’s Medical Research Commercialisation Fund managed by Brandon Capital (“MRCF”). 

Read the rest of entry »

Pages: Previous1234567...64NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.